Sign inJoin waitlistJoin the waitlist

Nabil Ahmed

Pediatric Oncology Honors Faculty Dream Team · Baylor College of Medicine

Credentials: · · ·

History

Rutgers New Jersey Medical School
2000–2001
Cairo University Hospitals
1999–2000
Pediatrics
1996–1999
Cairo University Hospitals
1995–1996
Cairo University in Cairo
Baylor College of Medicine
1991–1995

Research

Current concepts in the diagnosis and management of cytokine release syndrome
Case report · Blood · 2014 · 2,293 citations
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Journal of Clinical Oncology · 2015 · First of 26 authors · 855 citations
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
JAMA Oncology · 2017 · First of 33 authors · 747 citations

Meenakshi Hegde
34 papers
Stephen Gottschalk
26 papers
Helen Heslop
21 papers
Malcolm Brenner
13 papers
Kevin Bielamowicz
11 papers · 5 as a fellow
John Hicks
9 papers
Shoba Navai
9 papers · 2 as a fellow
Jordan Orange
8 papers
Bilal Omer
7 papers
Daniel Landi
7 papers · 5 as a fellow
Suzanne Powell
7 papers
AG
Alexia Ghazi
6 papers · 3 as a resident

Clinical trials

Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2023–2040
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
2021–2043
T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors
Principal investigator · Active not recruiting · Phase 1
Baylor College of Medicine
2016–2037
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Principal investigator · Terminated · Phase 1, Phase 2
Baylor College of Medicine
2010–2012